![The World Congress on Controversies in Obstetrics, Gynecology and Infertility (COGI). Click here to learn more.]({"type":"image" , "src" : "/sda/112382/JournalAd-COGI2024-Leaderboard.jpg"})
References
- American Diabetes Association. 2011. Diagnosis and classification of diabetes mellitus. Diabetes Care 34:S62–S69.
- Beneventi F, Simonetta M, Locatelli E, Cavagnoli C, Badulli C, Lovati E, et al. 2014. Temporal variation in soluble human leukocyte antigen‐G (sHLA‐G) and pregnancy‐associated plasma protein A (PAPP‐A) in pregnancies complicated by gestational diabetes mellitus and in controls. American Journal of Reproductive Immunology 72:413–421.
- Beneventi F, Simonetta M, Lovati E, Albonico G, Tinelli C, Locatelli E, et al. 2011. First trimester pregnancy-associated plasma protein-A in pregnancies complicated by subsequent gestational diabetes. Prenatal Diagnosis 31:523–528.
- Cheuk QK, Lo TK, Wong SF, Lee CP. 2016. Association between pregnancy-associated plasma protein-A levels in the first trimester and gestational diabetes mellitus in Chinese women. Hong Kong Medical Journal = Xianggang yi Xue Za Zhi 22:30–38.
- Dugoff L, Hobbins JC, Malone FD, Porter TF, Luthy D, Comstock CH, et al. 2004. First-trimester maternal serum PAPP-A and free-beta subunit human chorionic gonadotropin concentrations and nuchal translucency are associated with obstetric complications: a population-based screening study (the FASTER Trial). American Journal of Obstetrics and Gynecology 191:1446–1451.
- Husslein H, Lausegger F, Leipold H, Worda C. 2012. Association between pregnancy‐associated plasma protein‐A and gestational diabetes requiring insulin treatment at 11–14 weeks of gestation. Journal of Maternal Fetal and Neonatal Medicine 25:2230–2233.
- Lovati E, Beneventi F, Simonetta M, Laneri M, Quarleri L, Scudeller L, et al. 2013. Gestational diabetes mellitus: including serum pregnancy-associated plasma protein-A testing in the clinical management of primiparous women? A case–control study. Diabetes Research and Clinical Practice 100:340–347.
- Metzger BE, Lowe LP, Dyer AR, Trimble ER, Chaovarindr U, Coustan DR, et al. 2008. Hyperglycemia and adverse pregnancy outcomes. The New England Journal of Medicine 358:1991–2002.
- Ong CYT, Liao AW, Spencer K, Munim S, Nicolaides KH. 2000. First trimester maternal serum free β human chorionic gonadotrophin and pregnancy associated plasma protein A as predictor of pregnancy complication. BJOG: An International Journal of Obstetrics and Gynaecology 107:1265–1270.
- Peterson SE, Simhan HN. 2008. First-trimester pregnancy-associated plasma protein A and subsequent abnormalities of fetal growth. American Journal of Obstetrics and Gynecology 198:e43–e45.
- Petry CJ, Ong KK, Hughes IA, Acerini CL, Frystyk J, Dunger DB. 2017. Early pregnancy-associated plasma protein a concentrations are associated with third trimester insulin sensitivity. The Journal of Clinical Endocrinology and Metabolism 102:2000–2008.
- Savvidou MD, Syngelaki A, Muhaisen M, Emelyanenko E, Nicolaides KH. 2012. First trimester maternal serum free β-human chorionic gonadotropin and pregnancy-associated plasma protein A in pregnancies complicated by diabetes mellitus. BJOG: An International Journal of Obstetrics and Gynaecology 119:410–416.
- Spencer K, Cowans NJ. 2013. The association between gestational diabetes mellitus and first trimester aneuploidy screening markers. Annals of Clinical Biochemistry 50:603–610.
- Syngelaki A, Kotecha R, Pastides A, Wright A, Nicolaides KH. 2015. First-trimester biochemical markers of placentation in screening for gestational diabetes mellitus. Metabolism: Clinical and Experimental 64:1485–1489.
- Wells G, Bleicher K, Han X, McShane M, Chan YF, Bartlett A, et al. 2015. Maternal diabetes, large-for-gestational-age births, and first trimester pregnancy-associated plasma protein-A. The Journal of Clinical Endocrinology and Metabolism 100:2372–2379.
- World Health Organization. 2013. Diagnostic criteria and classification of hyperglycaemia first detected in pregnancy. Geneva, Switzerland: World Health Organization.
- Yaron Y, Ochshorn Y, Heifetz S, Lehavi O, Sapir Y, Orr-Urtreger A, et al. 2002. First trimester maternal serum free β human chorionic gonadotrophin as a predictor of adverse pregnancy outcome. Fetal Diagnosis and Therapy 17:352–356.